Evidence from humans also suggests a protective role for NK cells in MS: amelioration of MS by treatment with interferon-β [20] and anti-CD25 antibodies [21] or during pregnancy, correlates with expansion of presumed regulatory NK cells [22]. The gene discussed is IL2RA; the disease is myeloid sarcoma.